JP2012136552A - エマルション様水溶性濃縮物 - Google Patents
エマルション様水溶性濃縮物 Download PDFInfo
- Publication number
- JP2012136552A JP2012136552A JP2012062525A JP2012062525A JP2012136552A JP 2012136552 A JP2012136552 A JP 2012136552A JP 2012062525 A JP2012062525 A JP 2012062525A JP 2012062525 A JP2012062525 A JP 2012062525A JP 2012136552 A JP2012136552 A JP 2012136552A
- Authority
- JP
- Japan
- Prior art keywords
- emulsion
- water
- lecithin
- soluble concentrate
- lipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000004550 soluble concentrate Substances 0.000 title claims abstract description 15
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 22
- 239000000787 lecithin Substances 0.000 claims abstract description 19
- 229940067606 lecithin Drugs 0.000 claims abstract description 19
- 235000010445 lecithin Nutrition 0.000 claims abstract description 19
- 239000000126 substance Substances 0.000 claims abstract description 14
- 150000002632 lipids Chemical class 0.000 claims abstract description 13
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 10
- 229920005862 polyol Polymers 0.000 claims abstract description 10
- 150000003077 polyols Chemical class 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 150000003505 terpenes Chemical class 0.000 claims abstract 3
- 150000003431 steroids Chemical class 0.000 claims abstract 2
- 235000007586 terpenes Nutrition 0.000 claims abstract 2
- 239000012141 concentrate Substances 0.000 claims description 13
- 150000003904 phospholipids Chemical class 0.000 claims description 13
- 239000000243 solution Substances 0.000 claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 235000014633 carbohydrates Nutrition 0.000 claims description 7
- 239000002537 cosmetic Substances 0.000 claims description 7
- 239000004094 surface-active agent Substances 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- 239000000341 volatile oil Substances 0.000 claims description 3
- 239000012188 paraffin wax Substances 0.000 claims description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims 4
- 229940088594 vitamin Drugs 0.000 claims 4
- -1 glycerin phosphatide Chemical class 0.000 claims 3
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 claims 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 2
- 229930186217 Glycolipid Natural products 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 claims 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 claims 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 claims 1
- 241000251468 Actinopterygii Species 0.000 claims 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims 1
- 244000188595 Brassica sinapistrum Species 0.000 claims 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 claims 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims 1
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-threitol Chemical compound OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 claims 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 claims 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims 1
- 239000005913 Maltodextrin Substances 0.000 claims 1
- 229920002774 Maltodextrin Polymers 0.000 claims 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims 1
- 239000004164 Wax ester Substances 0.000 claims 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 claims 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 claims 1
- 229940036350 bisabolol Drugs 0.000 claims 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims 1
- 229940106189 ceramide Drugs 0.000 claims 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- 229940107161 cholesterol Drugs 0.000 claims 1
- 235000017471 coenzyme Q10 Nutrition 0.000 claims 1
- 229940110767 coenzyme Q10 Drugs 0.000 claims 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 150000002016 disaccharides Chemical class 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 150000002191 fatty alcohols Chemical class 0.000 claims 1
- 235000019688 fish Nutrition 0.000 claims 1
- 239000003862 glucocorticoid Substances 0.000 claims 1
- 125000005456 glyceride group Chemical group 0.000 claims 1
- FBPFZTCFMRRESA-UHFFFAOYSA-N hexane-1,2,3,4,5,6-hexol Chemical compound OCC(O)C(O)C(O)C(O)CO FBPFZTCFMRRESA-UHFFFAOYSA-N 0.000 claims 1
- 239000000845 maltitol Substances 0.000 claims 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims 1
- 235000010449 maltitol Nutrition 0.000 claims 1
- 229940035436 maltitol Drugs 0.000 claims 1
- 229940035034 maltodextrin Drugs 0.000 claims 1
- 229940041616 menthol Drugs 0.000 claims 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims 1
- 235000013336 milk Nutrition 0.000 claims 1
- 239000008267 milk Substances 0.000 claims 1
- 210000004080 milk Anatomy 0.000 claims 1
- 150000002772 monosaccharides Chemical class 0.000 claims 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 229920002545 silicone oil Polymers 0.000 claims 1
- 235000015500 sitosterol Nutrition 0.000 claims 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 claims 1
- 229950005143 sitosterol Drugs 0.000 claims 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 claims 1
- 150000003408 sphingolipids Chemical class 0.000 claims 1
- 150000005846 sugar alcohols Polymers 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 239000001993 wax Substances 0.000 claims 1
- 235000019386 wax ester Nutrition 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 8
- 239000011159 matrix material Substances 0.000 abstract description 3
- 239000003995 emulsifying agent Substances 0.000 description 13
- 239000000839 emulsion Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 230000007928 solubilization Effects 0.000 description 5
- 238000005063 solubilization Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000693 micelle Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000003381 solubilizing effect Effects 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 108010007979 Glycocholic Acid Proteins 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- RFDAIACWWDREDC-UHFFFAOYSA-N Na salt-Glycocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCC(O)=O)C)C1(C)C(O)C2 RFDAIACWWDREDC-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- RFDAIACWWDREDC-FRVQLJSFSA-N glycocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 RFDAIACWWDREDC-FRVQLJSFSA-N 0.000 description 1
- 229940099347 glycocholic acid Drugs 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 239000002960 lipid emulsion Substances 0.000 description 1
- 239000008206 lipophilic material Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 239000007908 nanoemulsion Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Colloid Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- General Preparation And Processing Of Foods (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Soft Magnetic Materials (AREA)
- Edible Oils And Fats (AREA)
Abstract
【解決手段】本発明の課題は、ポリオール溶液または炭化水素溶液の濃度が30質量%〜99質量%であり、レシチン:脂質の比が1:1〜1:12であり、かつポリオール溶液または炭水化物溶液中のレシチン/脂質混合物の濃度が10質量%〜90質量%である、脂肪様物質のエマルション様水溶性濃縮物およびその使用により達成される。
【選択図】なし
Description
−易揮発性アルコール−VOC−(エタノール、イソプロパノール)が、強い細胞毒性を有すること、および
−これらは、大気の保護を考慮すると、多くの配合物において望ましくないことである。
−乳化剤を、可溶化のために多量に使用しなければならないために、供給される作用物質の適用に関して、常に著量の添加剤を必要とすることである。一般的な方法において、たとえば1gのラベンダー油を可溶化するために、5gのPEG40水素化ヒマシ油を25%(w/w)エタノール性溶液中で必要とするか;さもなければ、一般的な方法において、たとえば20gのビタミンE−アセテートを可溶化するために、44gのPEG36水素化ヒマシ油および25gのプロピレングリコールを水溶液中で必要とする。さらに、親油性ビタミンA、EおよびDを一般的な方法で可溶化するためには、グリココール酸およびホスファチジルコリンの混合物の約10倍の過剰量を必要とする。
−レシチン/リン脂質と脂肪様物質との比は、問題なく水で希釈される透明な濃縮物が得られるように選択すべきであり、かつ、
−ポリオール−または炭水化物溶液の含水量は、透明な濃縮物が得られるばかりでなく、水の低い値に基づいて自己保存系(selbstkonservierendes System)が得られるように選択すべきであり、それによって、合成または同様に天然の保存剤の使用を回避することができる。
−工程温度は、使用されたレシチン/リン脂質または可溶化すべき脂質に適合させるべきである。水素化されたレシチン/リン脂質は、通常は、40〜80℃の工程温度を必要とし、不飽和のレシチン/リン脂質の場合には室温で処理されてもよく、その際、レシチン/リン脂質を好ましくは極性相中で、すなわちポリオール溶液または炭水化物溶液中に添加する。
PC−含量70%を有する大豆からのリン脂質画分5gを、86%グリセリン 75g中で撹拌することによって分散した。ビタミンE−アセテート20gを添加し、かつ連続的撹拌によって分散させた。これらの粗く分散された不均一な混合物を、高圧ホモジナイザーによってホモジナイズした。高粘度を有する透明なエマルション様溶液が得られた。
PC−含量70%を有する大豆からのリン脂質画分5gを、70%フルクトース溶液 75g中に撹拌することによって分散した。中鎖トリグリセリド 20gの添加後に、この混合物を高圧ホモジナイズすることによって、蜂蜜様の粘度を有する透明なエマルション様溶液が得られた。
Claims (11)
- リン脂質またはレシチンと、ポリオールまたは炭水化物の高濃度水溶液との組合せ物を用いての、脂肪様物質のエマルション様水溶性濃縮物において、ポリオール溶液または炭水化物溶液の濃度が30質量%〜99質量%であり、レシチン:脂質の比が1:1〜1:12であり、かつポリオール溶液または炭水化物溶液中のレシチン/脂質混合物の濃度が10質量%〜90質量%である、脂肪様物質のエマルション様水溶性濃縮物。
- 使用されたリン脂質またはレシチンのいずれかが不飽和であるか、水素化されているか、加水分解されているかヒドロキシ化されており、その際、レシチンまたはリン脂質は、大豆、ナタネ、魚、牛乳または卵から得られたものであって、かつ、レシチン画分が、ホスファチジルコリン含量10質量%〜100質量%を有する脱脂画分から形成されている、請求項1に記載のエマルション様水溶性濃縮物。
- レシチンが、少なくとも50質量%のアセトン不溶性物質を含有し、この場合、これらは、主に極性脂質、たとえばグリセリンホスファチド、スフィンゴホスファチド、スフィンゴグリコリピド、グリセリングリコリピドまたはアミノリピドの群からのものである、請求項1に記載のエマルション様水溶性濃縮物。
- ポリオールとして、好ましくは多価アルコールを使用し、その際、C3〜C6の炭素鎖を有するもの、たとえばグリセロール、トレイトール、ペンチトールまたはヘキシトールを使用する、請求項1に記載のエマルション様水溶性濃縮物。
- 炭水化物として、モノサッカリド、ジサッカリド、マルチトールまたはマルトデキシトリンを使用する、請求項1に記載のエマルション様水溶性濃縮物。
- 一価の易揮発性アルコール(VOC)および/またはエトキシル化界面活性剤または他の合成界面活性剤を使用しない、請求項1に記載のエマルション様水溶性濃縮物。
- 保存剤を使用しない、請求項1に記載のエマルション様水溶性濃縮物。
- 高圧ホモジナイザー、超音波またはローターステーターミキサを使用する、請求項1に記載のエマルション様水溶性濃縮物。
- 脂質(たとえば、脂肪酸、ワックス、ワックスエステル、パラフィン、脂肪族アルコール、脂肪族アルデヒド、グリセリド等)、イソプレノイド(テルペンおよびステロイド:たとえば、A−ビタミン、E−ビタミン、D−ビタミン、K−ビタミン、ビサボロール、メントール、グルココルチコイド、エッセンシャルオイル、コレステロール、シトステロール、コエンザイムQ10等)、極性脂質(セラミド、スフィンゴ脂質、グリコリピド等)ならびに油溶性UV−AおよびUV−Bフィルターおよびシリコーンオイルを使用する、請求項1に記載のエマルション様水溶性濃縮物。
- 化粧品、医薬品または食品のための、請求項1から9までのいずれか1項に記載のエマルション様水溶性濃縮物の使用。
- 局所、経口または非経口適用による、請求項9に記載の使用。
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10255195.2 | 2002-11-27 | ||
| DE10255195A DE10255195A1 (de) | 2002-11-27 | 2002-11-27 | Micellare wasserlösliche Konzentrate |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004554223A Division JP2006513172A (ja) | 2002-11-27 | 2003-11-25 | エマルション様水溶性濃縮物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012136552A true JP2012136552A (ja) | 2012-07-19 |
| JP5762340B2 JP5762340B2 (ja) | 2015-08-12 |
Family
ID=32308727
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004554223A Pending JP2006513172A (ja) | 2002-11-27 | 2003-11-25 | エマルション様水溶性濃縮物 |
| JP2012062525A Expired - Lifetime JP5762340B2 (ja) | 2002-11-27 | 2012-03-19 | エマルション様水溶性濃縮物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004554223A Pending JP2006513172A (ja) | 2002-11-27 | 2003-11-25 | エマルション様水溶性濃縮物 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20060159633A1 (ja) |
| EP (1) | EP1565163B1 (ja) |
| JP (2) | JP2006513172A (ja) |
| KR (1) | KR101153757B1 (ja) |
| CN (1) | CN1738603B (ja) |
| AT (1) | ATE543487T1 (ja) |
| AU (1) | AU2003294633B2 (ja) |
| BR (1) | BR0316731A (ja) |
| CA (1) | CA2507688C (ja) |
| CY (1) | CY1112824T1 (ja) |
| DE (2) | DE10255195A1 (ja) |
| DK (1) | DK1565163T3 (ja) |
| ES (1) | ES2381461T3 (ja) |
| IL (1) | IL168826A (ja) |
| MX (1) | MXPA05005720A (ja) |
| PT (1) | PT1565163E (ja) |
| RU (1) | RU2358715C2 (ja) |
| SI (1) | SI1565163T1 (ja) |
| UA (1) | UA86756C2 (ja) |
| WO (1) | WO2004047791A2 (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017197452A (ja) * | 2016-04-26 | 2017-11-02 | 照屋 亮 | 乳化組成物の製造方法 |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005005054A1 (de) | 2005-02-03 | 2006-08-10 | Karl Heinz Schubert | Hydrophile Biochinon-Verbindung, Verfahren zu ihrer Herstellung und ihre Verwendung |
| JP2006290841A (ja) * | 2005-04-14 | 2006-10-26 | Nippon Zettoc Co Ltd | 化粧料の製造方法および化粧料 |
| EP2034961A1 (de) * | 2006-06-30 | 2009-03-18 | Gertrud Langhoff | Solubilisatformulierungen |
| BRPI0603004A (pt) * | 2006-07-27 | 2007-01-16 | Walter Szortika Tessmann | fungicida natural à base de eucalyptus sp |
| US20080131515A1 (en) | 2006-12-01 | 2008-06-05 | Fujifilm Corporation | Emulsion composition, and foods and cosmetics containing the emulsion composition |
| US8846651B2 (en) * | 2007-03-01 | 2014-09-30 | Takasago International Corporation | Lipid composition having excellent shape retention property and product |
| ITMI20071914A1 (it) * | 2007-10-04 | 2009-04-05 | Sinerga S P A | Composizioni cosmetiche e dermofarmaceutiche per la ricostruzione e prevenzione dei disordini della barriera cutanea. |
| SG10202010355PA (en) | 2010-03-12 | 2020-11-27 | Berg Llc | Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
| DE102010033458B4 (de) | 2010-08-05 | 2016-03-10 | Helvista Ag | Emulgierte Lektinzusammensetzungen und ihre Verwendung |
| EP2720680B1 (en) | 2011-06-17 | 2020-02-12 | Berg LLC | Inhalable pharmaceutical compositions |
| DE102011105703A1 (de) | 2011-06-22 | 2012-12-27 | Wolfgang Langhoff | Diätetikum zur Behandlung mitochondrialer Dysfunktionen |
| JP5706349B2 (ja) * | 2012-02-01 | 2015-04-22 | 株式会社ファンケル | 安定なコエンザイムq10高濃度含有組成物 |
| KR101699035B1 (ko) * | 2014-10-27 | 2017-01-23 | 주식회사 엘지생활건강 | 오일겔상 무수 화장료 조성물 |
| US20170143011A1 (en) | 2015-11-25 | 2017-05-25 | Pepsico, Inc. | Beverage nanoemulstions produced by high shear processing |
| CN105832772B (zh) * | 2016-04-25 | 2019-08-27 | 中国林业科学研究院资源昆虫研究所 | 一种制备虫白蜡水溶液的方法 |
| CN110089658A (zh) * | 2018-01-31 | 2019-08-06 | 佛山市南海云丰生物科技有限公司 | 一种水溶性复配抗氧化剂的生产工艺及配方 |
| WO2019233552A1 (de) * | 2018-06-05 | 2019-12-12 | Pm-International Ag | Zweiphasiges system |
| EP4169386A1 (en) | 2021-10-19 | 2023-04-26 | Lipoid GmbH | Liquid composition containing a combination of vitamins a, d, e and k in a liquid matrix |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6025918A (ja) * | 1983-07-25 | 1985-02-08 | Ajinomoto Co Inc | 脂溶性薬物含有水性液 |
| JPS6295132A (ja) * | 1985-10-21 | 1987-05-01 | Nippon Saafuakutanto Kogyo Kk | 多価アルコ−ル中油型乳化組成物 |
| JPH01176443A (ja) * | 1987-12-28 | 1989-07-12 | Nonogawa Shoji:Kk | 多価アルコール中油型乳化組成物及び水中油型乳化組成物 |
| EP0760237A1 (en) * | 1995-08-30 | 1997-03-05 | Cipla Limited | Oil-in-water microemulsions |
| JPH10310517A (ja) * | 1997-03-12 | 1998-11-24 | Nissho Corp | 脂肪乳剤 |
| WO2000000178A1 (en) * | 1998-06-30 | 2000-01-06 | Rohto Pharmaceutical Co., Ltd. | Compositions containing liposomes and/or emulsions and process for the preparation thereof |
| JP2001072581A (ja) * | 1999-09-07 | 2001-03-21 | Noevir Co Ltd | 液状乳化型皮膚用組成物 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0753661B2 (ja) * | 1984-03-08 | 1995-06-07 | フアレス フアーマスーチカル リサーチ エヌブイ | プロ―リポソーム組成物及びリポソームの水性分散物を作る方法 |
| FR2575179B1 (fr) * | 1984-12-20 | 1987-02-06 | Roquette Freres | Procede de preparation de maltitol cristallise |
| US5168055A (en) * | 1986-06-11 | 1992-12-01 | Rathin Datta | Fermentation and purification process for succinic acid |
| US5206219A (en) * | 1991-11-25 | 1993-04-27 | Applied Analytical Industries, Inc. | Oral compositions of proteinaceous medicaments |
| FR2714596B1 (fr) * | 1993-12-30 | 1996-02-09 | Oreal | Composition cosmétique pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation. |
| DE4432378A1 (de) * | 1994-09-12 | 1996-03-14 | Bayer Ag | Injizierbare liposomale Arzneizubereitungen |
| EP0863192B1 (en) * | 1995-03-23 | 2003-12-17 | The Nisshin Oil Mills, Ltd. | Humectant composition, base containing the same, and cosmetic material or external preparation containing said humectant composition |
| DE19520659A1 (de) * | 1995-06-09 | 1996-12-12 | Mika Pharma Ges Fuer Die Entwi | Pharmazeutische Zubereitung zur Therapie und/oder Prophylaxe von durch Viren bedingten Erkrankungen der Haut und/oder der Schleimhaut |
| US6537561B1 (en) * | 1997-02-27 | 2003-03-25 | Nippon Shinyaku Co., Ltd. | Fat emulsion for oral administration |
| JPH11240829A (ja) * | 1998-02-23 | 1999-09-07 | Terumo Corp | 澄明な脂肪乳剤およびその製造方法 |
| BE1011899A6 (fr) * | 1998-04-30 | 2000-02-01 | Ucb Sa | Compositions pharmaceutiques gelifiables utilisables. |
| US6309656B1 (en) | 1998-11-27 | 2001-10-30 | Peter T. Pugliese | Cosmetic and skin protective compositions |
| DE19859427A1 (de) * | 1998-12-22 | 2000-06-29 | Beiersdorf Ag | Kosmetische oder pharmazeutische lecithinhaltige Gele oder niedrigviskose, lecithinhaltige O/W-Mikroemulsionen |
| DE19922193B4 (de) | 1999-05-12 | 2004-12-02 | Sonnenberg, Frank, Dipl.-Biol. | Wasserlösliches Konzentrat, bestehend aus ätherischen Ölen mikroverkapselt in einem Liposomensystem, ein Verfahren zu seiner Herstellung und die Verwendung |
| DE19940227A1 (de) * | 1999-08-25 | 2001-03-08 | Merckle Gmbh | Phospholipidgel |
-
2002
- 2002-11-27 DE DE10255195A patent/DE10255195A1/de not_active Withdrawn
-
2003
- 2003-11-25 UA UAA200506238A patent/UA86756C2/ru unknown
- 2003-11-25 AU AU2003294633A patent/AU2003294633B2/en not_active Expired
- 2003-11-25 JP JP2004554223A patent/JP2006513172A/ja active Pending
- 2003-11-25 US US10/536,384 patent/US20060159633A1/en not_active Abandoned
- 2003-11-25 BR BR0316731-3A patent/BR0316731A/pt not_active Application Discontinuation
- 2003-11-25 WO PCT/DE2003/003887 patent/WO2004047791A2/de not_active Ceased
- 2003-11-25 RU RU2005120159/15A patent/RU2358715C2/ru active
- 2003-11-25 DK DK03785529.3T patent/DK1565163T3/da active
- 2003-11-25 EP EP03785529A patent/EP1565163B1/de not_active Revoked
- 2003-11-25 MX MXPA05005720A patent/MXPA05005720A/es active IP Right Grant
- 2003-11-25 CN CN2003801084362A patent/CN1738603B/zh not_active Expired - Lifetime
- 2003-11-25 DE DE10394113T patent/DE10394113D2/de not_active Expired - Fee Related
- 2003-11-25 PT PT03785529T patent/PT1565163E/pt unknown
- 2003-11-25 SI SI200332138T patent/SI1565163T1/sl unknown
- 2003-11-25 CA CA2507688A patent/CA2507688C/en not_active Expired - Lifetime
- 2003-11-25 AT AT03785529T patent/ATE543487T1/de active
- 2003-11-25 KR KR1020057009707A patent/KR101153757B1/ko not_active Expired - Lifetime
- 2003-11-25 ES ES03785529T patent/ES2381461T3/es not_active Expired - Lifetime
-
2005
- 2005-05-26 IL IL168826A patent/IL168826A/en active IP Right Grant
-
2012
- 2012-03-19 JP JP2012062525A patent/JP5762340B2/ja not_active Expired - Lifetime
- 2012-04-25 CY CY20121100392T patent/CY1112824T1/el unknown
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6025918A (ja) * | 1983-07-25 | 1985-02-08 | Ajinomoto Co Inc | 脂溶性薬物含有水性液 |
| JPS6295132A (ja) * | 1985-10-21 | 1987-05-01 | Nippon Saafuakutanto Kogyo Kk | 多価アルコ−ル中油型乳化組成物 |
| JPH01176443A (ja) * | 1987-12-28 | 1989-07-12 | Nonogawa Shoji:Kk | 多価アルコール中油型乳化組成物及び水中油型乳化組成物 |
| EP0760237A1 (en) * | 1995-08-30 | 1997-03-05 | Cipla Limited | Oil-in-water microemulsions |
| JPH10310517A (ja) * | 1997-03-12 | 1998-11-24 | Nissho Corp | 脂肪乳剤 |
| WO2000000178A1 (en) * | 1998-06-30 | 2000-01-06 | Rohto Pharmaceutical Co., Ltd. | Compositions containing liposomes and/or emulsions and process for the preparation thereof |
| JP2001072581A (ja) * | 1999-09-07 | 2001-03-21 | Noevir Co Ltd | 液状乳化型皮膚用組成物 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2017197452A (ja) * | 2016-04-26 | 2017-11-02 | 照屋 亮 | 乳化組成物の製造方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2507688A1 (en) | 2004-06-10 |
| ES2381461T3 (es) | 2012-05-28 |
| IL168826A (en) | 2012-04-30 |
| DE10255195A1 (de) | 2004-06-09 |
| PT1565163E (pt) | 2012-05-08 |
| CY1112824T1 (el) | 2016-02-10 |
| EP1565163A2 (de) | 2005-08-24 |
| RU2358715C2 (ru) | 2009-06-20 |
| UA86756C2 (ru) | 2009-05-25 |
| SI1565163T1 (sl) | 2012-09-28 |
| AU2003294633B2 (en) | 2008-12-11 |
| HK1083755A1 (en) | 2006-10-27 |
| EP1565163B1 (de) | 2012-02-01 |
| JP2006513172A (ja) | 2006-04-20 |
| DK1565163T3 (da) | 2012-05-14 |
| ATE543487T1 (de) | 2012-02-15 |
| WO2004047791A2 (de) | 2004-06-10 |
| MXPA05005720A (es) | 2005-12-12 |
| RU2005120159A (ru) | 2006-01-27 |
| CN1738603A (zh) | 2006-02-22 |
| US20060159633A1 (en) | 2006-07-20 |
| BR0316731A (pt) | 2005-10-11 |
| AU2003294633A1 (en) | 2004-06-18 |
| CA2507688C (en) | 2011-06-14 |
| JP5762340B2 (ja) | 2015-08-12 |
| KR20050096919A (ko) | 2005-10-06 |
| DE10394113D2 (de) | 2005-10-20 |
| WO2004047791A3 (de) | 2004-09-02 |
| CN1738603B (zh) | 2012-09-05 |
| KR101153757B1 (ko) | 2012-06-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5762340B2 (ja) | エマルション様水溶性濃縮物 | |
| Flanagan et al. | Microemulsions: a potential delivery system for bioactives in food | |
| JP5393123B2 (ja) | 皮膚外用剤及びその製造方法 | |
| KR100835250B1 (ko) | 자기유화 전달체 및 이의 제조방법 | |
| JP7384518B2 (ja) | 難溶性成分安定化用組成物及びそれを含む化粧料組成物 | |
| EP0100459A2 (en) | An aqueous liquid containing a fat-soluble substance | |
| KR101116899B1 (ko) | 안정한 농축형 및 희석형 수중유형 에멀젼 | |
| CN104918600B (zh) | 乳液组合物及其用途 | |
| JPH09309813A (ja) | 皮膚外用剤 | |
| CN104936577B (zh) | 水包油型乳液组合物及其用途 | |
| US2276531A (en) | Water-dispersible vitamin composition | |
| JPS61129038A (ja) | 乳化組成物 | |
| KR20170107128A (ko) | 투명한 다중층 액정 조성물의 제조방법 | |
| HK1083755B (en) | Emulsive water-soluble concentrates | |
| KR900008312B1 (ko) | 비이온 활성제를 사용한 리포좀 혼합물 안정화 조성물 및 그 제조방법 | |
| JPH0686374B2 (ja) | 脂溶性物質含有水性液 | |
| US20060233846A1 (en) | Microdispersion and method of producing same | |
| EP4647060A1 (en) | Composition with emulsifying properties and uses thereof | |
| EP4635473A1 (en) | Oil-in-water emulsion composition | |
| JPH025837A (ja) | 多価アルコール中油型可溶化組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120417 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120417 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130816 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130826 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131125 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20131128 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131225 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140109 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140127 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140130 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140224 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140908 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150106 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20150114 |
|
| RD13 | Notification of appointment of power of sub attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7433 Effective date: 20150226 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20150226 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150330 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150403 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150511 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150609 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5762340 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |